These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37839353)

  • 1. The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease.
    Li HY; Liu DS; Zhang YB; Rong H; Zhang XJ
    Biophys Chem; 2023 Dec; 303():107122. PubMed ID: 37839353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
    Wang R; Sun H; Ren H; Wang G
    Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
    Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease.
    Negi S; Khurana N; Duggal N
    Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lewy body in Parkinson's disease and related neurodegenerative disorders.
    Wakabayashi K; Tanji K; Odagiri S; Miki Y; Mori F; Takahashi H
    Mol Neurobiol; 2013 Apr; 47(2):495-508. PubMed ID: 22622968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
    Sengupta U; Kayed R
    Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation.
    Li J; Ng KW; Sung CC; Chung KKK
    J Neurochem; 2024 Jul; 168(7):1215-1236. PubMed ID: 38693066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-specific pluripotent stem cell-based Parkinson's disease models showing endogenous alpha-synuclein aggregation.
    Oh Y
    BMB Rep; 2019 Jun; 52(6):349-359. PubMed ID: 31186086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.
    Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J
    J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.
    Wakabayashi K; Tanji K; Mori F; Takahashi H
    Neuropathology; 2007 Oct; 27(5):494-506. PubMed ID: 18018486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease.
    Riederer P; Nagatsu T; Youdim MBH; Wulf M; Dijkstra JM; Sian-Huelsmann J
    J Neural Transm (Vienna); 2023 May; 130(5):627-646. PubMed ID: 37062012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease.
    Yao MF; Dang T; Wang HJ; Zhu XZ; Qiao C
    Behav Brain Res; 2024 Feb; 459():114811. PubMed ID: 38103871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
    Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
    Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.
    Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A
    Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.
    Olivares D; Huang X; Branden L; Greig NH; Rogers JT
    Int J Mol Sci; 2009 Mar; 10(3):1226-60. PubMed ID: 19399246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein: membrane interactions and toxicity in Parkinson's disease.
    Auluck PK; Caraveo G; Lindquist S
    Annu Rev Cell Dev Biol; 2010; 26():211-33. PubMed ID: 20500090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.